FDA Approves Hibsago Drug for Hepatitis B Treatment
The US FDA has approved Hibsago, a new drug for treating chronic Hepatitis B. This approval marks a significant step forward, offering new hope to patients who can now stop taking traditional antiviral medications. The drug works by targeting the virus effectively, potentially improving treatment outcomes for Hepatitis B sufferers.
Jansatta·



